HelloBetter Secures $3 Million Funding to Revolutionize Digital Therapeutics for Mental Health and Beyond

HelloBetter, a pioneering company in the field of digital therapeutics for mental health, is excited to announce that it has successfully raised €3 million in its latest funding round. Founded in 2015, HelloBetter has established itself as a European leader in digital mental health, supported by the most robust evidence base in the industry, with 33 randomized controlled trials published in esteemed peer-reviewed journals. This funding will be pivotal in advancing HelloBetter's mission to enhance mental wellness access across the globe, particularly as the company expands its reach into new markets. A significant portion of the raised funds will be allocated to further developing and enhancing its digital therapeutic program, HelloBetter Panic, which recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This recognition underscores the product's innovative approach to treating panic disorder, signaling potential transformative impacts for patients. Additionally, the funding will bolster the growth of HelloGina, HelloBetter’s brand launched in the U.S. that focuses on a sexual wellness program for individuals experiencing vaginismus. With six therapy programs already incorporated into Germany’s standard of care, HelloBetter is set to leverage this financial boost to create even more accessible mental health solutions for patients worldwide. By addressing pressing mental health issues through digital means, HelloBetter remains committed to its vision of empowering individuals to take control of their mental wellness, ensuring that effective treatment options are both accessible and user-friendly.